Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Diseases × Acetaminophen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 9 Neoplasms 7 Agnosia 5 Multiple Myeloma 4 Hodgkin Disease 4 Pain, Postoperative 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Lung Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Cancer Pain 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Philadelphia Chromosome 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell 2 Leukemia, Myeloid, Acute 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Acute Pain 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1

Interventions

entinostat 4 exemestane 3 Trastuzumab 2 Docetaxel 2 Cyclophosphamide 2 ribociclib 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1 dactolisib 1 atezolizumab 1 Zoledronic Acid 1 Trabectedin 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Paclitaxel 1 Leflunomide 1 Ibuprofen 1 High-Energy Shock Waves 1 Fulvestrant 1 Fentanyl 1 Exercise 1 Everolimus 1 Erlotinib Hydrochloride 1 Educational Status 1 Doxorubicin 1 Codeine 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡